BioCurex News

NEWS	Subscribe / unsubscribe to BioCurex news

BioCurex Announces New OncoPet Sample Collection Kit Ready to Ship to Distributors and Veterinarians

Test Modification Significantly Reduces Shipping Costs for Veterinarians
Sep. 26th, 2011

BioCurex's RECAF^TM Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies
Sep 8th, 2011

BioCurex Presents Latest Advances on Its Proprietary Peptide RECAF(TM) Test in International Cancer Congress
Aug 25th, 2011

BioCurex, Inc. Strengthens Management Team and Board of Directors
July 20, 2011

BioCurex Updates Its Shareholders
June 27, 2011

International Peer Reviewed Scientific Journal Publishes BioCurex Article Showing That a Combination of its Cancer Marker RECAF and CA125 Can be Used for Ovarian Cancer Screening
June 8, 2011

BioCurex Contracts CaroLink Science Solutions to Pursue Strategy for 510(k) Filing
June 2, 2011

BioCurex Subsidiary Continues Marketing Expansion of its RECAF(TM) Test in Asia
May 13, 2011

BioCurex Subsidiary OncoPet Diagnostics Signs Distribution Agreement With Success Vision Biotek Inc. for RECAF(TM) Test for Companion Animals
May 3, 2011

BioCurex Updates Its Shareholders On Technical and Business Advances
Apr 14th, 2011

BioCurex Management interview with Wall Street Reporter
Jan 13th, 2011

BioCurex Hosts Shareholder Call for a Shareholder Update (click to replay call)
Dec 3th, 2010

BioCurex Announces Filing of New Patent For Cancer Diagnostics, Therapeutics Based on its Proprietary RECAF™ Technology
Nov 3rd, 2010

BioCurex Announces Distribution Agreement for the European Union for its OncoPet RECAF™ Cancer Test for Animals
Oct 13th, 2010

BioCurex CEO Highlights Recent Presentation of its RECAF Test at International Scientific Meeting on Cancer Markers
Sep 20th, 2010

BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
Jul 29, 2010

BioCurex Announces Positive First Results for Monitoring Cancer Therapy Using its RECAF Blood Test.
July 8, 2010

BioCurex, Inc. Executive Chairman Denis Burger to Present at the Renowned BIO International Convention in Chicago on May 6, 2010
May 6th, 2010

Company BioCurex, Inc. Executive Chairman Writes to Shareholders. Company to host Shareholder Call Tuesday, Feb. 23, 2010 at 4:10 p.m. EST for Update
February 18th, 2010

BioCurex Announces Commercialization of OncoPet RECAF(TM), the First Blood Test for Cancer Detection in Companion Animals
Feb. 11, 2010

BioCurex Announces Receipt of Additional Proceeds From Public Offering
Jan 29th, 2010

BioCurex Announces Effectiveness of a $6 Million Public Offering.
January 19th, 2010

BioCurex Presents Positive Results At International Oncology and Biomarkers Congress With Its RECAF(TM) Cancer Marker.
September 29th, 2009

BioCurex Completes Private Placement Financing.
September 17th, 2009

BioCurex Appoints Two New Directors.
September 9, 2009

BioCurex Introduces OncoPetTM, a RECAFTM Blood Test For Cancer Detection In Companion Animals. No Regulatory Approvals Required Prior to Commercialization.
June 17th, 2009

BioCurex Updates Its Shareholders.
May 1st, 2009

BioCurex Reports On Presentation of RECAF Results At the 'XII International Symposium On Biology and Clinical Usefulness of Tumor Markers' Held in Europe.
February 19, 2009

BioCurex Incorporates Chinese Subsidiary, Prepares to Tap World's Largest Cancer-Testing Market.
November 5th, 2008

Warren Buffett Recommends Buying Stock in USA Companies: "Be fearful when others are greedy, and be greedy when others are fearful".
Read his comments published in The New York Times on the opportunities created by the current financial market's turmoil.
October 17, 2008

BioCurex Update Following the 2008 ISOBM Congress. RECAF Triggers Interest for Multiple Collaborations.
October 15, 2008- Source: BioCurex Inc.
More information

RECAF Test Detects Lung, Breast and Gastrointestinal Cancers Using a Drop of Saliva-Work Done in Collaboration with the Goshen Center for Cancer Care.
October 3, 2008- Source: BioCurex Inc.
More information

BioCurex Obtains First Patent on Therapeutic Applications for Proprietary RECAF marker.
Sept 17, 2008- Source: BioCurex Inc.
More information

BioCurex Comments on Market Activity
July 3, 2008- Source: BioCurex Inc.
More information

BioCurex develops NEW format for its RECAF cancer blood test. Results confirm its accuracy.
May 28, 2008- Source: BioCurex Inc.
More information

Crystal Research Associates issues Research Report on BioCurex.
April 28, 2008- Source: BioCurex Inc.
More information

European Patent Office Grants Patent for BioCurex's RECAF Blood Tests
March 25, 2008- Source: BioCurex Inc.
More information

BioCurex Announces Amendments to Licensing Agreement
March 20, 2008- Source: BioCurex Inc.
More information

BioCurex Gains Second Major RECAF Licensing Agreement
January 10, 2008- Source: BioCurex Inc.
More information

BioCurex Licenses RECAF Technology to Inverness Medical Innovations
January 9, 2008- Source: BioCurex Inc.
More information

BioCurex and Dr. Stewart Sell Wins ISOBM-Abbott Award
September 25, 2007- Source: BioCurex Inc.
More information

BioCurex and Abbott Jointly Present RECAF Results at International Cancer Congresss
September 20, 2007- Source: BioCurex Inc.
More information

BioCurex Presents RECAFTM Point-of-Care Test Results at International Cancer Congress
September 18, 2007- Source: BioCurex Inc.
More information

BioCurex Comments on Genetic Testing and RECAF Technology
July 8, 2007- Source: BioCurex Inc.
More information

BioCurex Signs Consent to Transfer Abbott’s RECAF Licensing Agreement to General Electric
July 2, 2007- Source: BioCurex Inc.
More information

BioCurex Rapid Tests
June 5, 2007- Source: BioCurex Inc.
More information

BioCurex Continues to Progress; a Corporate Status Review
May 2, 2007- Source: BioCurex Inc.
More information

BioCurex Begins Development of Unique “POINT-OF-CARE” Test For Cancer With Estimated Market Size Of $1B.
February 13, 2007- Source: BioCurex Inc.
More information

Biocurex Enters Collaboration Agreement With Largest Cancer Research Center in Russia.
December 07, 2006 - Source: BioCurex Inc.
More information

BioCurex discusses PSA article from the Journal of the National Cancer Institute
November 07, 2006 - Source: BioCurex Inc.
More information

Where to Watch our Interview
http://www.yourcancertoday.com/wheretowatch.asp

BioCurex to appear on Your Cancer Today show
October 31, 2006 - Source: BioCurex Inc.
More information

BioCurex presents new format for blood test detection of cancer with results superior to PSA
October 25, 2006 - Source: BioCurex Inc.
More information

Independent results support the use of BioCurex technology for Gastric Cancer
October 17, 2006 - Source: BioCurex Inc.
More information

BioCurex returns to the OTC:BB
August 22, 2006 - Source: BioCurex Inc.
More information

BioCurex Presents Results At The Largest Clinical Lab Meeting In North America.
July 18, 2006 - Source: BioCurex Inc.
More information

Prostate Cancer Detected Very Early With RECAF Blood Test
May 16, 2006 - Source: BioCurex Inc.
More information

BioCurex Progresses
April 27, 2006 - Source: BioCurex Inc.
More information

BioCurex Blood Test Detects Very Early Stages of Breast Cancer With High Specificity.
April 11, 2006 - Source: BioCurex Inc.
More information

NEWS